GCP
CEMI

GSA Capital Partners’s Chembio diagnostics, Inc. CEMI Stock Holding History

GSA Capital Partners’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-30,880
Closed -$92K – 1935
2021
Q2 		$92K Buy
+30,880
New +$108K 0.01% 1252

Other funds holding CEMI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

GSA Capital Partners's CEMI Position: Q3 2021 in Review

GSA Capital Partners sold out of Chembio diagnostics, Inc. (CEMI) in Q3 2021, closing a stake of 30,880 shares — an estimated $92K sold.

GSA Capital Partners first reported a position in CEMI in Q2 2021 and held it in 1 quarter. The position peaked at $92K in Q2 2021. 47 funds tracked by Wall St. Rank hold CEMI as of Q3 2021.

  • GSA Capital Partners reported no remaining Chembio diagnostics, Inc. position as of Q3 2021 after selling out during the quarter.
  • GSA Capital Partners sold 30,880 Chembio diagnostics, Inc. shares in Q3 2021, an estimated $92K.
  • GSA Capital Partners first reported a position in Chembio diagnostics, Inc. in Q2 2021 and held it in 1 quarter.
  • GSA Capital Partners's Chembio diagnostics, Inc. position peaked at $92K in Q2 2021.
  • 47 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q3 2021.

Based on GSA Capital Partners's 13F filing for Q3 2021, filed 12 Nov 2021.